Meagan B. Myers

925 total citations
39 papers, 681 citations indexed

About

Meagan B. Myers is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Meagan B. Myers has authored 39 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Meagan B. Myers's work include Cancer Genomics and Diagnostics (15 papers), Molecular Biology Techniques and Applications (9 papers) and DNA Repair Mechanisms (8 papers). Meagan B. Myers is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Molecular Biology Techniques and Applications (9 papers) and DNA Repair Mechanisms (8 papers). Meagan B. Myers collaborates with scholars based in United States, United Kingdom and Japan. Meagan B. Myers's co-authors include Barbara L. Parsons, Robert H. Heflich, Mugimane G. Manjanatha, Magomed Khaidakov, Anane Aidoo, Malathi Banda, Yiying Wang, Yiying Wang, Page B. McKinzie and T.G. Myers and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Cancer Research.

In The Last Decade

Meagan B. Myers

39 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meagan B. Myers United States 17 336 291 185 104 102 39 681
Xuan Su China 16 469 1.4× 240 0.8× 119 0.6× 55 0.5× 114 1.1× 57 799
Mirtha S. Lopez United States 13 305 0.9× 256 0.9× 102 0.6× 47 0.5× 86 0.8× 19 564
Ishrat Mahjabeen Pakistan 19 683 2.0× 348 1.2× 203 1.1× 83 0.8× 59 0.6× 73 948
Tsung‐Hua Hsieh Taiwan 17 419 1.2× 256 0.9× 185 1.0× 47 0.5× 37 0.4× 31 1.2k
Pengyun Qiao China 17 436 1.3× 252 0.9× 153 0.8× 79 0.8× 54 0.5× 23 779
Wan-Ju Kim United States 15 559 1.7× 209 0.7× 267 1.4× 107 1.0× 112 1.1× 26 819
Anamika Basu United States 16 324 1.0× 223 0.8× 105 0.6× 103 1.0× 66 0.6× 21 877
Céline Levalois France 14 577 1.7× 202 0.7× 258 1.4× 82 0.8× 93 0.9× 18 878
Jilin Li China 17 453 1.3× 241 0.8× 234 1.3× 55 0.5× 120 1.2× 51 840
Sheelu Varghese United States 11 270 0.8× 160 0.5× 296 1.6× 33 0.3× 136 1.3× 14 886

Countries citing papers authored by Meagan B. Myers

Since Specialization
Citations

This map shows the geographic impact of Meagan B. Myers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meagan B. Myers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meagan B. Myers more than expected).

Fields of papers citing papers by Meagan B. Myers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meagan B. Myers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meagan B. Myers. The network helps show where Meagan B. Myers may publish in the future.

Co-authorship network of co-authors of Meagan B. Myers

This figure shows the co-authorship network connecting the top 25 collaborators of Meagan B. Myers. A scholar is included among the top collaborators of Meagan B. Myers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meagan B. Myers. Meagan B. Myers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Faske, Jennifer, et al.. (2024). CarcSeq detection of lorcaserin-induced clonal expansion ofPik3caH1047R mutants in rat mammary tissue. Toxicological Sciences. 201(1). 129–144. 3 indexed citations
3.
Marchetti, Francesco, Connie L. Chen, George R. Douglas, et al.. (2023). Error-corrected next generation sequencing – Promises and challenges for genotoxicity and cancer risk assessment. Mutation Research/Reviews in Mutation Research. 792. 108466–108466. 30 indexed citations
4.
McKinzie, Page B. & Meagan B. Myers. (2023). A Brief Practical Guide to PCR. Methods in molecular biology. 2621. 3–13. 1 indexed citations
5.
Myers, Meagan B. & Cynthia A. Schandl. (2023). Clinical Applications of Nucleic Acid Amplification. Methods in molecular biology. 1 indexed citations
6.
Banda, Malathi, et al.. (2020). Outgrowth of erlotinib-resistant subpopulations recapitulated in patient-derived lung tumor spheroids and organoids. PLoS ONE. 15(9). e0238862–e0238862. 16 indexed citations
7.
Myers, Meagan B., et al.. (2020). ACB-PCR Quantification of Low-Frequency Hotspot Cancer-Driver Mutations. Methods in molecular biology. 2102. 395–417. 3 indexed citations
8.
Myers, Meagan B., et al.. (2019). Low-Frequency Mutational Heterogeneity of Invasive Ductal Carcinoma Subtypes: Information to Direct Precision Oncology. International Journal of Molecular Sciences. 20(5). 1011–1011. 8 indexed citations
9.
Nicholson, Anna M., Richard Kemp, Philip Quirke, et al.. (2018). Fixation and Spread of Somatic Mutations in Adult Human Colonic Epithelium. Cell stem cell. 22(6). 909–918.e8. 72 indexed citations
10.
Luderer, Ulrike, et al.. (2017). Ovarian effects of prenatal exposure to benzo[a]pyrene: Roles of embryonic and maternal glutathione status. Reproductive Toxicology. 69. 187–195. 10 indexed citations
11.
Myers, Meagan B.. (2016). Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives. Pharmacogenomics and Personalized Medicine. 9. 7–7. 21 indexed citations
12.
Myers, Meagan B., et al.. (2014). ACB-PCR Quantification of Somatic Oncomutation. Methods in molecular biology. 1105. 345–363. 11 indexed citations
13.
Parsons, Barbara L., Mugimane G. Manjanatha, Meagan B. Myers, et al.. (2013). Temporal Changes in K-ras Mutant Fraction in Lung Tissue of Big Blue B6C3F1 Mice Exposed to Ethylene Oxide. Toxicological Sciences. 136(1). 26–38. 20 indexed citations
14.
O’Brien, Travis J., Hao Ding, Mina Suh, et al.. (2013). Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 754(1-2). 15–21. 35 indexed citations
15.
Wang, Yiying, Meagan B. Myers, Brian A. Wong, et al.. (2011). p53 codon 271 CGT to CAT mutant fraction does not increase in nasal respiratory and olfactory epithelia of rats exposed to inhaled naphthalene. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 721(2). 199–205. 11 indexed citations
16.
Parsons, Barbara L., et al.. (2010). Oncomutations as biomarkers of cancer risk. Environmental and Molecular Mutagenesis. 51(8-9). 836–850. 25 indexed citations
17.
Myers, Meagan B., Roberta A. Mittelstaedt, & Robert H. Heflich. (2009). Using ΦX174 DNA as an Exogenous Reference for Measuring Mitochondrial DNA Copy Number. BioTechniques. 47(4). 867–869. 15 indexed citations
18.
Khaidakov, Magomed, Robert H. Heflich, Mugimane G. Manjanatha, Meagan B. Myers, & Anane Aidoo. (2003). Accumulation of point mutations in mitochondrial DNA of aging mice. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 526(1-2). 1–7. 95 indexed citations
19.
Myers, Meagan B., et al.. (1984). Psychosocial consequences of childhood cancer survival. American Journal of Epidemiology. 120(3). 480. 1 indexed citations
20.
Christine, B., et al.. (1973). Hodgkin's disease in Connecticut: histology and age distribution.. PubMed. 36. 3–8. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026